BRUSX
Price
$31.57
Change
-$1.77 (-5.31%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

BRUSX vs VSIAX

Header iconBRUSX vs VSIAX Comparison
Open Charts BRUSX vs VSIAXBanner chart's image
Bridgeway Ultra-Small
Price$31.57
Change-$1.77 (-5.31%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
BRUSX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRUSX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRUSX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. BRUSX (95.1M). VSIAX pays higher dividends than BRUSX: VSIAX (2.01) vs BRUSX (0.00). BRUSX was incepted earlier than VSIAX: BRUSX (30 years) vs VSIAX (13 years). BRUSX is a more actively managed with annual turnover of: 74.00 vs. VSIAX (16.00). BRUSX has a lower initial minimum investment than VSIAX: BRUSX (2000) vs VSIAX (3000). BRUSX annual gain was more profitable for investors over the last year : 24.94 vs. VSIAX (16.23). VSIAX return over 5 years is better than : 52.83 vs. BRUSX (40.75).
BRUSXVSIAXBRUSX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years13 years-
Gain YTD16.77015.031112%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets95.1M63B0%
Annual Yield % from dividends0.002.01-
Returns for 1 year24.9416.23154%
Returns for 3 years2.8820.6714%
Returns for 5 years40.7552.8377%
Returns for 10 years12.96105.6512%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics